US Patent 8404862 Ligand-conjugated monomers

Patent 8404862 was granted and assigned to Alnylam Pharmaceuticals on March, 2013 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Alnylam Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8404862

Date of Patent

March 26, 2013

Patent Application Number

12497262

Date Filed

July 2, 2009

Patent Citations Received

‌

US Patent 12116573 Targeting ligands for therapeutic compounds

‌

US Patent 11851655 Compositions and methods for modulating apolipoprotein (a) expression

‌

US Patent 12013403 Compositions and methods for detection of SMN protein in a subject and treatment of a subject

Patent Primary Examiner

‌

Shawquia Young

Patent abstract

This invention relates composition and methods for making and using chemically modified oligonucleotides agents for inhibiting gene expression.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8404862 Ligand-conjugated monomers

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API